587 related articles for article (PubMed ID: 7905019)
1. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
[TBL] [Abstract][Full Text] [Related]
2. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
3. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
4. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
[TBL] [Abstract][Full Text] [Related]
5. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.
Powrie F; Leach MW; Mauze S; Caddle LB; Coffman RL
Int Immunol; 1993 Nov; 5(11):1461-71. PubMed ID: 7903159
[TBL] [Abstract][Full Text] [Related]
6. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
8. Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells.
D'Império Lima MR; Alvarez JM; Furtado GC; Kipnis TL; Coutinho A; Minóprio P
Scand J Immunol; 1996 Mar; 43(3):263-70. PubMed ID: 8602459
[TBL] [Abstract][Full Text] [Related]
9. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.
Asseman C; Read S; Powrie F
J Immunol; 2003 Jul; 171(2):971-8. PubMed ID: 12847269
[TBL] [Abstract][Full Text] [Related]
10. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
11. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
Varkila K; Chatelain R; Leal LM; Coffman RL
Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179
[TBL] [Abstract][Full Text] [Related]
13. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
[TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Jun; 164(11):6005-14. PubMed ID: 10820284
[TBL] [Abstract][Full Text] [Related]
15. TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RBhigh T lymphocytes into nude mice.
Kanai T; Kawamura T; Dohi T; Makita S; Nemoto Y; Totsuka T; Watanabe M
Inflamm Bowel Dis; 2006 Feb; 12(2):89-99. PubMed ID: 16432372
[TBL] [Abstract][Full Text] [Related]
16. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions.
Launois P; Gumy A; Himmelrich H; Locksley RM; Röcken M; Louis JA
J Immunol; 2002 May; 168(9):4628-35. PubMed ID: 11971011
[TBL] [Abstract][Full Text] [Related]
17. Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens.
Zhou P; Borojevic R; Streutker C; Snider D; Liang H; Croitoru K
J Immunol; 2004 Feb; 172(3):1515-23. PubMed ID: 14734729
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
Scott P
J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice.
Xu D; Liu H; Komai-Koma M; Campbell C; McSharry C; Alexander J; Liew FY
J Immunol; 2003 Jan; 170(1):394-9. PubMed ID: 12496424
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
